GO Term | Evidence Code | PMID |
---|---|---|
endothelial cell migration | ||
ganglion development | ||
positive regulation of receptor signaling pathway via JAK-STAT | ||
positive regulation of vascular endothelial growth factor production | ||
membrane lipid catabolic process |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11476 | osteoporosis | |
DOID:11541 | recurrent corneal erosion | |
DOID:11612 | polycystic ovary syndrome | |
DOID:1168 | familial hyperlipidemia | |
DOID:11714 | gestational diabetes | |
DOID:11847 | coronary thrombosis | |
DOID:11934 | head and neck cancer | |
DOID:11984 | hypertrophic cardiomyopathy | |
DOID:1227 | neutropenia | |
DOID:12270 | coloboma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000486 | Strabismus |
HP:0000501 | Glaucoma |
HP:0000505 | Visual impairment |
HP:0000523 | Subcapsular cataract |
HP:0000525 | Abnormality iris morphology |
HP:0000541 | Retinal detachment |
HP:0000557 | Buphthalmos |
HP:0000572 | Visual loss |
HP:0000587 | Abnormal optic nerve morphology |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
123799824 | URSAM29251 | ||
100466967 | AILME17244 | ||
101676151 | MUSPF07886 | ||
101099873 | FELCA08013 | ||
122216410 | PANLE02648 | ||
101319238 | TURTR14145 | ||
118906405 | BALMU05300 | ||
100655003 | LOXAF08443 | ||
100070088 | HORSE09336 | ||
100625479 | PIGXX22235 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024